Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 17/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.71 |
| ▸ | CASP1 | P29466 | 2/20 | 0.71 |
| ▸ | CASP7 | P55210 | 2/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13201683 | 0.87 | ALDH1A1 (0.77) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL30736438 | 0.87 | ALDH1A1 (0.77) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL30940173 | 0.86 | ALDH1A1 (0.75) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL19878307 | 0.86 | ALDH1A1 (0.75) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL24715839 | 0.85 | ALDH1A1 (0.74) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL10158686 | 0.83 | ALDH1A1 (1.00) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL9073375 | 0.83 | ALDH1A1 (0.81) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL30626621 | 0.82 | ALDH1A1 (0.74) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL27190053 | 0.82 | ALDH1A1 (0.74) | ALDH1A1NPSR1HPGDHSD17B10CASP1 | |
| SCHEMBL27172713 | 0.82 | ALDH1A1 (0.69) | ALDH1A1NPSR1HPGDHSD17B10CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9034877-B2 | Bifunctional/polyfunctional dopamine D2/D3 agonist as neuroprotective agents for treatment of neurodegenerative diseases | WAYNE STATE UNIVERSITY (US) | 2015-05-19 | — | — | US | disclosed |
| US-20120108815-A1 | BIFUNCTIONAL/POLYFUNCTIONAL DOPAMINE D2/D3 AGONIST AS NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | WAYNE STATE UNIVERSITY (US) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108815-A1 | BIFUNCTIONAL/POLYFUNCTIONAL DOPAMINE D2/D3 AGONIST AS NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | DRD3, DRD2, SLC6A3 | ALDH1A1 3688/4885NPSR1 212/4885HPGD 1541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.